MEDCO HEALTH SOLUTIONS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 99 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-12-11: Reporting owner ROPER WILLIAM L; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-12-11: Reporting owner POTTER MYRTLE S; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-11-30: Reporting owner Moriarty Thomas M; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2007-11-30: Reporting owner Moriarty Thomas M; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-12-11 | ROPER WILLIAM L Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200 200 owned after | $98.33 exercise price | 2007-12-12 | |
| 2007-12-11 | POTTER MYRTLE S Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200 200 owned after | $98.33 exercise price | 2007-12-12 | |
| 2007-11-30 | Moriarty Thomas M Officer (Senior Vice President) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,600 7,200 owned after | $56.34 exercise price | 2007-12-03 | |
| 2007-11-30 | Moriarty Thomas M Officer (Senior Vice President) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,700 12,700 owned after | $99.99 exercise price | 2007-12-03 | |
| 2007-11-30 | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 10,000 owned after | $32.51 exercise price | 2007-12-03 | |
| 2007-11-29 | DRISCOLL JOHN PATRICK Officer (Pres. - Insured & Emerg. Mrkt.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,933 9,467 owned after | $44.19 exercise price | 2007-11-30 | |
| 2007-11-13 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 12,000 owned after | $58.48 exercise price | 2007-11-13 | |
| 2007-11-05 | TAYLOR GLENN C Officer (Group President, Key Accounts) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −65,000 0 owned after | $32.51 exercise price | 2007-11-07 | |
| 2007-11-05 | RUBINO RICHARD J Officer (SVP & Controller) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,334 0 owned after | $26.92 exercise price | 2007-11-07 | |
| 2007-11-05 | RUBINO RICHARD J Officer (SVP & Controller) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,334 0 owned after | $32.51 exercise price | 2007-11-07 | |
| 2007-11-05 | RUBINO RICHARD J Officer (SVP & Controller) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,667 0 owned after | $34.72 exercise price | 2007-11-07 | |
| 2007-11-05 | RUBINO RICHARD J Officer (SVP & Controller) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,520 4,260 owned after | $44.19 exercise price | 2007-11-07 | |
| 2007-09-21 holding as of filing | Moriarty Thomas M Officer (Senior Vice President) | 3 | Stock Option Derivative · Direct | Holding | $44.19 exercise price | 2007-09-21 | ||
| 2007-09-21 holding as of filing | Moriarty Thomas M Officer (Senior Vice President) | 3 | Stock Option Derivative · Direct | Holding | $56.34 exercise price | 2007-09-21 | ||
| 2007-09-21 holding as of filing | Moriarty Thomas M Officer (Senior Vice President) | 3 | Stock Option Derivative · Direct | Holding | $67.39 exercise price | 2007-09-21 | ||
| 2007-09-10 | NARDIN ARTHUR H Officer (SVP, Pharma Contracting) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,200 7,100 owned after | $44.19 exercise price | 2007-09-11 | |
| 2007-09-10 | NARDIN ARTHUR H Officer (SVP, Pharma Contracting) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,200 14,400 owned after | $58.48 exercise price | 2007-09-11 | |
| 2007-08-31 | WENTWORTH TIMOTHY C Officer (President & CEO - Accredo) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,230 21,230 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | TAYLOR GLENN C Officer (Group President, Key Accounts) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,400 19,400 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,220 7,220 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | RUBINO RICHARD J Officer (SVP & Controller) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,420 2,420 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | REED JOANN A Officer (SVP, Finance and CFO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,550 17,550 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,200 5,200 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | NARDIN ARTHUR H Officer (SVP, Pharma Contracting) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,760 6,760 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | MACHLOWITZ DAVID Officer (SVP, General Counsel & Secy.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,840 7,840 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,270 7,270 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,560 9,560 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,400 19,400 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | EPSTEIN ROBERT S Officer (SVP Medical Affairs & CMO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,100 8,100 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | EPSTEIN ROBERT S Officer (SVP Medical Affairs & CMO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,280 32,380 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | DRISCOLL JOHN PATRICK Officer (Pres. - Insured & Emerg. Mrkt.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,400 19,400 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-31 | BIRCH BRYAN D Officer (President, Employer Accounts) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,400 19,400 owned after | $85.45 exercise price | 2007-09-05 | |
| 2007-08-07 | DRISCOLL JOHN PATRICK Officer (Pres. - Insured & New Markets) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,334 0 owned after | $32.51 exercise price | 2007-08-09 | |
| 2007-08-07 | EPSTEIN ROBERT S Officer (SVP Medical Affairs & CMO) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,400 13,000 owned after | $32.51 exercise price | 2007-08-07 | |
| 2007-08-06 | SNOW DAVID B JR Director, Officer (Chairman and CEO) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −317,100 0 owned after | $26.92 exercise price | 2007-08-08 | |
| 2007-08-06 | EPSTEIN ROBERT S Officer (SVP Medical Affairs & CMO) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −600 37,400 owned after | $32.51 exercise price | 2007-08-07 | |
| 2007-06-18 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $32.51 exercise price | 2007-06-19 | |
| 2007-05-25 | EPSTEIN ROBERT S Officer (SVP Medical Affairs & CMO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +49,605 49,605 owned after | $78.62 exercise price | 2007-05-29 | |
| 2007-05-24 | WILSON BLENDA J Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,100 3,100 owned after | $77.73 exercise price | 2007-05-29 | |
| 2007-05-24 | STEVENS DAVID D Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,100 3,100 owned after | $77.73 exercise price | 2007-05-29 | |
| 2007-05-24 | SHORTLIFFE EDWARD H Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,100 3,100 owned after | $77.73 exercise price | 2007-05-29 | |
| 2007-05-24 | LILLIS CHARLES M Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,100 3,100 owned after | $77.73 exercise price | 2007-05-29 | |
| 2007-05-24 | LEWIN LAWRENCE S Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,100 3,100 owned after | $77.73 exercise price | 2007-05-29 | |
| 2007-05-24 | GOLDSTEIN MICHAEL Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,100 3,100 owned after | $77.73 exercise price | 2007-05-29 | |
| 2007-05-24 | CASSIS JOHN L Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,100 3,100 owned after | $77.73 exercise price | 2007-05-29 | |
| 2007-05-24 | BARKER HOWARD W JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,100 3,100 owned after | $77.73 exercise price | 2007-05-29 | |
| 2007-04-24 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 10,000 owned after | $32.51 exercise price | 2007-04-26 | |
| 2007-04-24 | NARDIN ARTHUR H Officer (SVP, Pharma Contracting) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $32.51 exercise price | 2007-04-26 | |
| 2007-04-24 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,000 0 owned after | $32.51 exercise price | 2007-04-26 | |
| 2007-04-24 | BIRCH BRYAN D Officer (President, Employer Accounts) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 0 owned after | $34.72 exercise price | 2007-04-26 | |
| 2007-04-23 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 50,000 owned after | $34.72 exercise price | 2007-04-24 | |
| 2007-04-23 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 0 owned after | $34.72 exercise price | 2007-04-24 | |
| 2007-04-04 | WENTWORTH TIMOTHY C Officer (President & CEO - Accredo) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,323 9,162 owned after | $44.19 exercise price | 2007-04-05 | |
| 2007-04-04 | NARDIN ARTHUR H Officer (SVP, Pharma Contracting) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 10,000 owned after | $32.51 exercise price | 2007-04-05 | |
| 2007-04-02 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 40,000 owned after | $32.51 exercise price | 2007-04-04 | |
| 2007-04-02 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,200 7,100 owned after | $44.19 exercise price | 2007-04-03 | |
| 2007-04-02 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,000 26,000 owned after | $32.51 exercise price | 2007-04-03 | |
| 2007-04-02 | BIRCH BRYAN D Officer (President, Employer Accounts) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 0 owned after | $32.51 exercise price | 2007-04-03 | |
| 2007-03-19 | REED JOANN A Officer (SVP, Finance and CFO) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −90,096 0 owned after | $27.59 exercise price | 2007-03-20 | |
| 2007-03-19 | REED JOANN A Officer (SVP, Finance and CFO) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −90,000 0 owned after | $26.92 exercise price | 2007-03-20 | |
| 2007-03-12 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,112 0 owned after | $26.92 exercise price | 2007-03-13 | |
| 2007-03-08 | BIRCH BRYAN D Officer (President, Employer Accounts) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 0 owned after | $26.92 exercise price | 2007-03-09 | |
| 2007-03-07 | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $26.92 exercise price | 2007-03-07 | |
| 2007-03-06 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $26.92 exercise price | 2007-03-07 | |
| 2007-03-06 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −65,320 0 owned after | $27.59 exercise price | 2007-03-07 | |
| 2007-03-06 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −149,934 0 owned after | $26.92 exercise price | 2007-03-07 | |
| 2007-03-06 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −70,000 0 owned after | $26.92 exercise price | 2007-03-07 | |
| 2007-03-02 | WENTWORTH TIMOTHY C Officer (President & CEO - Accredo) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,334 0 owned after | $32.51 exercise price | 2007-03-05 | |
| 2007-02-28 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,334 0 owned after | $32.51 exercise price | 2007-03-02 | |
| 2007-02-27 holding as of filing | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 3/A | Stock Option Derivative · Direct | Holding | $26.92 exercise price | 2007-02-27 | ||
| 2007-02-27 holding as of filing | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 3/A | Stock Option Derivative · Direct | Holding | $32.51 exercise price | 2007-02-27 | ||
| 2007-02-27 holding as of filing | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 3/A | Stock Option Derivative · Direct | Holding | $44.19 exercise price | 2007-02-27 | ||
| 2007-02-27 holding as of filing | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 3/A | Stock Option Derivative · Direct | Holding | $56.34 exercise price | 2007-02-27 | ||
| 2007-02-23 | RUBINO RICHARD J Officer (SVP & Controller) | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,380 10,380 owned after | $67.39 exercise price | 2007-02-28 | |
| 2007-02-23 | WENTWORTH TIMOTHY C Officer (President & CEO - Accredo) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,015 22,015 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | TAYLOR GLENN C Officer (Group President, Key Accounts) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,015 22,015 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | SNOW DAVID B JR Director, Officer (Chairman and CEO & Dir.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +326,565 326,565 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,610 17,610 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | RUBINO RICHARD J Officer (SVP & Controller) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,380 10,380 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | REED JOANN A Officer (SVP, Finance and CFO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,450 31,450 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,610 17,610 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | NARDIN ARTHUR H Officer (SVP, Pharma Contracting) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,385 21,385 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | MACHLOWITZ DAVID Officer (SVP, General Counsel & Secy.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,130 20,130 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,610 17,610 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,610 56,610 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,015 22,015 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | EPSTEIN ROBERT S Officer (SVP Medical Affairs & CMO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,610 17,610 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | DRISCOLL JOHN PATRICK Officer (Pres. - Insured & New Markets) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,480 36,480 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-23 | BIRCH BRYAN D Officer (President, Employer Accounts) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,015 22,015 owned after | $67.39 exercise price | 2007-02-27 | |
| 2007-02-21 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 10,000 owned after | $26.92 exercise price | 2007-02-23 | |
| 2007-02-21 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,111 22,223 owned after | $26.92 exercise price | 2007-02-23 | |
| 2007-02-21 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,111 11,112 owned after | $26.92 exercise price | 2007-02-23 | |
| 2007-02-21 | EPSTEIN ROBERT S Officer (SVP Medical Affairs & CMO) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,667 0 owned after | $26.92 exercise price | 2007-02-23 | |
| 2007-02-21 | DRISCOLL JOHN PATRICK Officer (Pres. - Insured & Emerging Mkt) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,667 0 owned after | $26.92 exercise price | 2007-02-23 | |
| 2007-02-21 | DRISCOLL JOHN PATRICK Officer (Pres. - Insured & Emerging Mkt) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,333 23,334 owned after | $32.51 exercise price | 2007-02-23 | |
| 2007-01-30 holding as of filing | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 3 | Stock Option Derivative · Direct | Holding | $26.92 exercise price | 2007-01-30 | ||
| 2007-01-30 holding as of filing | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 3 | Stock Option Derivative · Direct | Holding | $32.51 exercise price | 2007-01-30 | ||
| 2007-01-30 holding as of filing | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 3 | Stock Option Derivative · Direct | Holding | $44.19 exercise price | 2007-01-30 | ||
| 2007-01-30 holding as of filing | Kornwasser Laizer Officer (SVP, Channel & Generic Stratg.) | 3 | Stock Option Derivative · Direct | Holding | $56.34 exercise price | 2007-01-30 |